Respiratory patients are most vulnerable to the effects of climate change

People living with lung conditions, such as asthma and chronic obstructive pulmonary disease (COPD), face even greater risks from climate change, according to an expert report published today (Monday) in the European Respiratory Journal.

Biden administration to use Defense Production Act to tackle drug shortages

President Joe Biden is directing HHS to use the Defense Production Act to boost the production of drugs in shortage, he wrote in a memo

January 4, 2024

New Study Says LSD and Psilocybin Could Outperform Opioids for Pain, Without Developing Tolerance

Most people put pain and depression in two separate categories, myself included. But when a doctor recently explained that PTSD and depression hurt too, the

November 29, 2023

Sanofi sells rare disease drug Enjaymo to Recordati for $825M upfront

Sanofi is offloading its rare autoimmune disease medicine Enjaymo to an Italian pharmaceutical company for $825 million upfront. Recordati, based in Milan, Sign up to

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.